These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Anion-π Interactions in Computer-Aided Drug Design: Modeling the Inhibition of Malate Synthase by Phenyl-Diketo Acids. Ellenbarger JF; Krieger IV; Huang HL; Gómez-Coca S; Ioerger TR; Sacchettini JC; Wheeler SE; Dunbar KR J Chem Inf Model; 2018 Oct; 58(10):2085-2091. PubMed ID: 30137983 [TBL] [Abstract][Full Text] [Related]
6. Long-range effects in anion-π interactions: their crucial role in the inhibition mechanism of Mycobacterium tuberculosis malate synthase. Bauzá A; Quiñonero D; Deyà PM; Frontera A Chemistry; 2014 Jun; 20(23):6985-90. PubMed ID: 24740694 [TBL] [Abstract][Full Text] [Related]
7. Structure based virtual screening and discovery of novel inhibitors against FabD protein of Sundararajan S; Karunakaran K; Muniyan R J Biomol Struct Dyn; 2024 Aug; 42(12):6280-6291. PubMed ID: 37424186 [TBL] [Abstract][Full Text] [Related]
8. Pharmacophore model-based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against Naz S; Farooq U; Khan S; Sarwar R; Mabkhot YN; Saeed M; Alsayari A; Muhsinah AB; Ul-Haq Z J Biomol Struct Dyn; 2021 Feb; 39(2):610-620. PubMed ID: 31937192 [TBL] [Abstract][Full Text] [Related]
9. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations. Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488 [TBL] [Abstract][Full Text] [Related]
10. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of Kumari M; Subbarao N J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360 [TBL] [Abstract][Full Text] [Related]
11. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis. Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941 [TBL] [Abstract][Full Text] [Related]
12. Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria. Nyambo K; Tapfuma KI; Adu-Amankwaah F; Julius L; Baatjies L; Niang IS; Smith L; Govender KK; Ngxande M; Watson DJ; Wiesner L; Mavumengwana V Sci Rep; 2024 Mar; 14(1):6794. PubMed ID: 38514663 [TBL] [Abstract][Full Text] [Related]
13. Refined homology model of cytochrome bcc complex B subunit for virtual screening of potential anti-tuberculosis agents. Pan Z; Wang Y; Gu X; Wang J; Cheng M J Biomol Struct Dyn; 2020 Oct; 38(16):4733-4745. PubMed ID: 31674290 [TBL] [Abstract][Full Text] [Related]
15. Flavanones: A potential natural inhibitor of the ATP binding site of PknG of Swain SP; Gupta S; Das N; Franca TCC; Goncalves ADS; Ramalho TC; Subrahmanya S; Narsaria U; Deb D; Mishra N J Biomol Struct Dyn; 2022; 40(22):11885-11899. PubMed ID: 34409917 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
17. Glyoxylate detoxification is an essential function of malate synthase required for carbon assimilation in Puckett S; Trujillo C; Wang Z; Eoh H; Ioerger TR; Krieger I; Sacchettini J; Schnappinger D; Rhee KY; Ehrt S Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2225-E2232. PubMed ID: 28265055 [TBL] [Abstract][Full Text] [Related]
18. Computational assessment of Singh A; Kumar S; Gupta VK; Singh S; Dwivedi VD; Mina U J Biomol Struct Dyn; 2023 Jul; 41(11):4903-4916. PubMed ID: 35549811 [TBL] [Abstract][Full Text] [Related]
19. Copper transporter protein (MctB) as a therapeutic target to elicit antimycobacterial activity against tuberculosis. Dwivedi M; Jose S; Gupta M; Devi SS; Raj R; Kumar D J Biomol Struct Dyn; 2024 Jul; 42(10):5334-5348. PubMed ID: 37340670 [TBL] [Abstract][Full Text] [Related]
20. The product complex of M. tuberculosis malate synthase revisited. Anstrom DM; Remington SJ Protein Sci; 2006 Aug; 15(8):2002-7. PubMed ID: 16877713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]